DWTX Dogwood Therapeutics, Inc.

Fundamentals / CIK 0001818844 / USD

Dogwood Therapeutics, Inc. reported $75.61M in total assets and a net loss of $25.18M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DWTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$0$0$0-$32.03MFY 2020 Net Income: -$10.35M2020FY 2021 Net Income: -$15.96M2021FY 2022 Net Income: -$12.25M2022FY 2023 Net Income: -$5.30M2023FY 2024 Net Income: -$12.35M2024FY 2025 Net Income: -$34.26M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $21.87M $3.53M $1.73M $8.07M $10.80M $194K
Total Operating Expenses $27.97M $12.23M $5.45M $12.32M $15.64M $10.01M
Operating Income -$27.97M -$12.23M -$5.45M -$12.32M -$15.64M -$10.01M
EBITDA -$27.97M -$12.22M -- -- -- --
Income Before Tax -$34.04M -$12.35M -$5.30M -$12.25M -$15.96M -$10.35M
Income Tax Expense $221K -$503 -- -- -- --
Net Income -$34.26M -$12.35M -$5.30M -$12.25M -$15.96M -$10.35M
Basic EPS -$7.13 -$12.52 -$0.28 -$1.11 -$1.92 -$2.10
Diluted EPS -$7.13 -$12.52 -$0.28 -$1.11 -$1.92 -$2.10
Basic Shares Outstanding 5.0M 1.0M 18.8M 11.1M 8.3M 4.9M
Diluted Shares Outstanding 5.0M 1.0M 18.8M 11.1M 8.3M 4.9M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $100K -- -- -- -- -- -- --
Cost of Revenue $88K -- -- -- -- -- -- --
Gross Profit $12K -- -- -- -- -- -- --
Research & Development $3.35M $3.25M $2.67M $2.34M $14.52M $2.57M $2.44M $2.32M
Total Operating Expenses $4.93M $14.06M $5.08M $3.81M $15.81M $3.92M $4.43M $7.54M
Operating Income -$4.92M -$14.06M -$5.08M -$3.81M -$15.81M -$3.92M -$4.43M -$7.54M
EBITDA -- -- -- -$3.81M -$15.84M -$3.91M -$4.41M --
Income Before Tax -$4.88M -$14.01M -$4.99M -$3.75M -$15.75M -$3.81M -$10.73M -$7.73M
Net Income -$4.88M -$11.53M -$4.99M -$3.78M -$15.74M -$3.81M -$10.92M -$7.73M
Basic EPS -$0.14 -$0.34 -$0.15 -- -$8.20 -$1.99 -$8.45 --
Diluted EPS -$0.14 -$0.34 -$0.15 -- -$8.20 -$1.99 -$8.45 --
Basic Shares Outstanding 34.1M 34.1M 33.5M -- 1.9M 1.9M 1.4M --
Diluted Shares Outstanding 34.1M 34.1M 33.5M -- 1.9M 1.9M 1.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $6.52M $14.85M $3.32M $7.03M $14.01M $29.80M
Cash & Short-Term Investments $6.52M $14.85M $3.32M $7.03M $14.01M $29.80M
Total Current Assets $8.43M $16.54M $4.17M $8.37M $15.78M $31.47M
Property, Plant & Equipment, Net $13K $17K -- -- -- --
Goodwill $12.40M $11.81M -- -- -- --
Intangible Assets $68.99M $65.71M -- -- -- --
Total Non-Current Assets $81.74M $77.76M $0 $0 $0 $0
Total Assets $90.17M $94.31M $4.17M $8.37M $15.78M $31.47M
Accounts Payable $761K $1.23M $112K $573K $354K $369K
Total Current Liabilities $3.06M $3.18M $359K $1.04M $1.28M $1.53M
Other Non-Current Liabilities -- $15.38M -- -- -- --
Total Non-Current Liabilities $12.22M $26.85M $0 $0 $0 $0
Total Liabilities $15.27M $30.03M $359K $1.04M $1.28M $1.53M
Total Debt (incl. Leases) $163K $205K -- -- -- --
Common Stock $3.0K $133 $77 $1.8K $833 $830
Retained Earnings -$108.1M -$73.82M -$61.47M -$56.17M -$43.93M -$27.97M
Accumulated Other Comp. Income -$587K -$3.86M -- -- -- --
Total Stockholders' Equity $74.90M -$10.12M $3.81M $7.33M $14.50M $29.94M
Total Equity $74.90M -$10.12M $3.81M $7.33M $14.50M $29.94M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $4.95M $9.61M $13.23M $6.52M $10.13M $13.40M $17.54M $14.85M
Cash & Short-Term Investments $4.95M $9.61M $13.23M $6.52M $10.13M $13.40M $17.54M $14.85M
Total Current Assets $6.04M $11.03M $15.00M $8.43M $11.66M $14.70M $19.16M $16.54M
Property, Plant & Equipment, Net $12K $12K $13K $13K $15K $16K $16K $17K
Goodwill $11.98M $11.96M $12.19M $12.40M $12.21M $12.46M $11.82M $11.81M
Intangible Assets $57.44M $57.35M $67.83M $68.99M $67.92M $69.30M $65.77M $65.71M
Total Non-Current Assets $69.56M $69.47M $80.20M $81.74M $80.34M $81.99M $77.82M $77.76M
Total Assets $75.61M $80.50M $95.21M $90.17M $91.99M $96.69M $96.98M $94.31M
Accounts Payable $170K $412K $144K $761K $585K $498K $1.15M $1.23M
Total Current Liabilities $2.17M $2.83M $2.56M $3.06M $2.60M $1.89M $2.58M $3.18M
Other Non-Current Liabilities -- -- -- -- -- -- -- $15.38M
Total Non-Current Liabilities $9.30M $9.30M $12.02M $12.22M $12.01M $12.27M $11.66M $26.85M
Total Liabilities $11.47M $12.13M $14.58M $15.27M $14.61M $14.15M $14.24M $30.03M
Total Debt (incl. Leases) $118K $127K $145K $163K $175K $187K $191K $205K
Common Stock $3.4K $3.4K $3.3K $3.0K $229 $191 $191 $133
Retained Earnings -$129.5M -$124.6M -$113.1M -$108.1M -$104.3M -$88.55M -$84.74M -$73.82M
Accumulated Other Comp. Income -$2.90M -$2.99M -$1.72M -$587K -$1.64M -$267K -$3.80M -$3.86M
Total Stockholders' Equity $64.13M $68.37M $80.62M $74.90M $7.26M $6.88M $7.09M -$10.12M
Total Equity $64.13M $68.37M $80.62M $74.90M $7.26M $6.88M $7.09M -$10.12M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$34.26M -$12.35M -$5.30M -$12.25M -$15.96M -$10.35M
Depreciation & Amortization $2.1K $12K -- -- -- --
Stock-Based Compensation $356K $476K $620K $583K $323K $7.43M
Change in Payables -$533K $220K -$461K $219K $270K $52K
Operating Cash Flow -$15.62M -$8.79M -$4.87M -$11.47M -$15.69M -$3.90M
Investing Cash Flow -- $3.76M -- -- -- --
Common Stock Issued -- -- $1.16M -- -- --
Financing Cash Flow $7.28M $16.70M $1.16M $4.49M -$98K $33.38M
Net Change in Cash -$8.33M $11.68M -$3.71M -$6.98M -$15.79M $29.49M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$4.88M -$11.53M -$4.99M -$3.78M -$15.74M -$3.81M -$10.92M -$7.73M
Depreciation & Amortization -- -- -- $0 -$32K $17K $17K --
Stock-Based Compensation $558K $543K $449K $158K $48K $65K $84K $94K
Change in Payables -$246K $264K -$590K $119K $87K -$607K -$131K -$123K
Operating Cash Flow -$4.64M -$3.61M -$4.59M -$3.64M -$3.27M -$4.03M -$4.68M -$6.13M
Financing Cash Flow $50 $23 $11.29M $33K $0 -$120K $7.37M --
Net Change in Cash -$4.64M -$3.61M $6.70M -$3.60M -$3.27M -$4.15M $2.69M $12.95M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -45.7% -- -139.1% -167.2% -110.1% -34.6%
Return on Assets (ROA) -38.0% -13.1% -127.1% -146.3% -101.2% -32.9%
Current Ratio 2.76x 5.21x 11.62x 8.02x 12.37x 20.55x
Quick Ratio 2.13x 4.67x 9.25x 6.74x 10.98x 19.45x
Debt to Equity 0.00x -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -39.3% -52.7% -35.1% -45.7% -526.4% -359.7% -310.2% --
Return on Assets (ROA) -33.3% -44.8% -29.7% -38.0% -41.5% -25.6% -22.7% -13.1%
Current Ratio 2.78x 3.89x 5.86x 2.76x 4.49x 7.80x 7.43x 5.21x
Quick Ratio 2.28x 3.39x 5.17x 2.13x 3.90x 7.11x 6.80x 4.67x
Debt to Equity 0.00x 0.00x 0.00x 0.00x 0.02x 0.03x 0.03x --
Source: SEC EDGAR CompanyFacts (CIK 0001818844) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:53 UTC · Open in terminal